Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
28/10/2016 HPRA MIMS Article October 2016 : Implanon NXT and risk of device migration in vasculature and lung 3rd Party Publications
25/10/2016 Blincyto (blinatumomab) - Important Safety Information from AMGEN Ireland Limited as approved by the HPRA 3rd Party Publications
17/10/2016 Unlicensed homeopathic teething products Warning
28/09/2016 Incompatibility of Various Glass Pre-filled Syringe Products with Certain Needle-free Connection Systems Advisory
06/09/2016 Recall of Four Batches of GlucaGen HypoKit to Patient Level in Ireland Recall
29/08/2016 Pro-Epanutin (fosphenytoin sodium) - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA 3rd Party Publications
24/08/2016 Zydelig (idelalisib) - Important Safety Information from Gilead Sciences Ltd as approved by the HPRA 3rd Party Publications
16/08/2016 HPRA IMF Article August 2016-Valproate containing medicines. New educational materials available for healthcare professionals and patients 3rd Party Publications
16/08/2016 Humalog (insulin lispro) - Important Safety Information from Eli Lilly and Co (Ireland) Limited as approved by the HPRA 3rd Party Publications
11/08/2016 HPRA MIMS Article August 2016 Miconazole and warfarin - reminder of the potential for interaction 3rd Party Publications